Analysis of Benefit-Risk Balance in Decision-Making of the Food and Drug Administration for Premarket Approval of Therapeutic Medical Devices

Advanced Biomedical Engineering - Japan
doi 10.14326/abe.2.101
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society for Medical and Biological Engineering

Related search

Inclusion of Training Patients in US Food and Drug Administration Premarket Approval Cardiovascular Device Studies

Archives of Internal Medicine
2011English

U.S. Food and Drug Administration Approval: Ruxolitinib for the Treatment of Patients With Intermediate and High-Risk Myelofibrosis

Clinical Cancer Research
Cancer ResearchOncology
2012English

Assessment of Clinical Trials Supporting US Food and Drug Administration Approval of Novel Therapeutic Agents, 1995-2017

JAMA network open
Medicine
2020English

U.S. Food and Drug Administration Approval: Cabozantinib for the Treatment of Advanced Renal Cell Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2016English

Transparency and Dermatologic Device Approval by the US Food and Drug Administration

JAMA Dermatology
DermatologyMedicine
2018English

Medical Decision Making and Decision Analysis

Anaesthesia and Intensive Care
Critical CareAnesthesiologyPain MedicineIntensive Care Medicine
1988English

Have Thoracic Endografting Outcomes Improved Since US Food and Drug Administration Approval?

Annals of Thoracic Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2011English

Devices, Drugs, and the Food and Drug Administration: Increasing Implications for Ischemic Stroke

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2005English

Food and Drug Administration Drug Approval Summary: Sunitinib Malate for the Treatment of Gastrointestinal Stromal Tumor and Advanced Renal Cell Carcinoma

Oncologist
Cancer ResearchMedicineOncology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy